| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advancing drug repurposing research: Trends, collaborative networks, innovation and knowledge leaders
|
Albuquerque, Priscila C.
|
|
|
27 |
12 |
p.
|
artikel
|
| 2 |
Assessment of the breakthrough-therapy-designated drugs granted in China: A pooled analysis 2020–2022
|
Luo, Xingxian
|
|
|
27 |
12 |
p.
|
artikel
|
| 3 |
Contents page
|
|
|
|
27 |
12 |
p.
|
artikel
|
| 4 |
Deep learning methods for molecular representation and property prediction
|
Li, Zhen
|
|
|
27 |
12 |
p.
|
artikel
|
| 5 |
Evidence-based support for phenotypic drug discovery in acute myeloid leukemia
|
Vandersluis, Sean
|
|
|
27 |
12 |
p.
|
artikel
|
| 6 |
Inorganic nanoparticle-based advanced cancer therapies: Promising combination strategies
|
Amaldoss, Maria John Newton
|
|
|
27 |
12 |
p.
|
artikel
|
| 7 |
Intranasal delivery of biotechnology-based therapeutics
|
Patel, Dhrumi
|
|
|
27 |
12 |
p.
|
artikel
|
| 8 |
Machine learning methods for pK a prediction of small molecules: Advances and challenges
|
Wu, Jialu
|
|
|
27 |
12 |
p.
|
artikel
|
| 9 |
The Unitary Patent and UPC – Implications for the pharmaceutical sector
|
Mummery, Zack
|
|
|
27 |
12 |
p.
|
artikel
|
| 10 |
Trends in small molecule drug properties: A developability molecule assessment perspective
|
Agarwal, Prashant
|
|
|
27 |
12 |
p.
|
artikel
|
| 11 |
What is the importance of difference in LCM strategy in drug development? – Learnings from Keytruda and Opdivo
|
Kodama, Kota
|
|
|
27 |
12 |
p.
|
artikel
|
Tijdschrift beschrijving